Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Placebo-controlled, Double-blind Study to Evaluate the Efficacy of 2LHERP® in Patients With Recurrent Genital Herpes Infections

NCT04235322 is registered in ClinicalTrials.gov with Labo'Life as lead sponsor.

NCT NCT04235322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04235322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Placebo-controlled, Double-blind Study to Evaluate the Efficacy of 2LHERP® in Patients With Recurrent Genital Herpes Infections
Lead sponsor
Labo'Life
Phase
Phase 4
Overall status
Terminated
Start date
January 25, 2021
Completion date
April 18, 2023
Enrollment
6 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

herpes simplex, genital